Showing results (1911-1920 of 3,030) with videos related to

Sort By:
Pageof 303
Journal of Molecular Medicine (Berlin, Germany)|October 18, 2021
COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term viewIvana von Metzler, Julia Campe, Sabine Huenecke, et al.
Acta Ophthalmologica|January 17, 2018
Choroidal thickness and myopia in relation to physical activity - the CHAMPS Eye StudyKristian Lundberg, Anders Højslet Vestergaard, Nina Jacobsen, et al.
Advances in Therapy|June 28, 2018
Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2- Metastatic Breast CancerAnnie Guérin, Debbie Goldschmidt, Tania Small, et al.
Pediatric Transplantation|May 6, 2018
Side effects and efficacy of renal sparing immunosuppression in pediatric liver transplantation-A single center matched cohort studyChristoph Leiskau, Jeremy Rajanayagam, Eva-Doreen Pfister, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 5, 2019
Carfilzomib-Dexamethasone Versus Bortezomib-Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Overall Survival, Safety, and SubgroupsRobert Z Orlowski, Philippe Moreau, Ruben Niesvizky, et al.
Physical Review Letters|October 13, 2007
Dynamic and thermodynamic properties of porous vortex matter in Bi(2)Sr(2)CaCu(2)O(8) in an oblique magnetic fieldNurit Avraham, Y Y Goldschmidt, J T Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemiaI Blazsek, C Farabos, M Musset, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myelomaJens Hillengass, Klaus Wasser, Stefan Delorme, et al.
Cancer|June 24, 2010
Activity and tolerability of nilotinib: a retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerantMaya Koren-Michowitz, Philipp le Coutre, Justus Duyster, et al.
Hematological Oncology|March 16, 2013
Sorafenib in patients with refractory or recurrent multiple myelomaAnna Yordanova, Dirk Hose, Kai Neben, et al.
Pageof 303